Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000530736 | SCV000642377 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 2024-08-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys219Serfs*2) in the SGCB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCB are known to be pathogenic (PMID: 15938573, 18285821). This variant is present in population databases (no rsID available, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with SGCB-related conditions. ClinVar contains an entry for this variant (Variation ID: 466603). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000530736 | SCV002783200 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 2024-06-05 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000530736 | SCV004201000 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 2024-03-30 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000530736 | SCV004238646 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 2023-07-11 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000530736 | SCV000790743 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 2017-04-06 | no assertion criteria provided | clinical testing |